血小板活化因子与慢性自发性荨麻疹关系的研究进展

Abstract
Figure/Table
References (33)
Related Citation (15)

Download: PDF (541 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Chronic spontaneous urticaria is a special type of chronic urticaria. Mast cell disorder and basophil activation and degranulation are considered to be the center of this process. In the course of pathogenesis, it stimulates the release of platelet activating factors related to allergic inflammation. In addition, platelet activating factor is a very important pathogenic component that can cause severe allergic reactions. It can also activate mast cells and aggravate inflammatory reactions, which has gradually attracted attention in this research field. In this paper, the current research on the relationship between platelet activating factor and chronic spontaneous urticaria will be sorted out to provide a new direction for the effective prevention and treatment of chronic spontaneous urticaria.

Key words： Platelet activating factor Chronic spontaneous urticaria Inflammatory reaction Research progress

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Mengli1 GUO Jianhui1
	2 ZHAO Na1
	2 GUO Wen1
	2 GONG Ke1 WANG Fang1 DU Kaiqing1 ZHANG Man1

Cite this article:

LI Mengli1 GUO Jianhui1,2 ZHAO Na1,2 GUO Wen1, et al. Research progress on relationship between platelet activating factor and chronic spontaneous urticaria[J]. 中国医药导报, 2021, 18(13): 39-42.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I13/39

[1] Zuberbier T，Aberer W，Asero R，et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition，classification，diagnosis and management of urticaria [J]. Allergy，2018（73）：1393-1414.
[2] Kolkhir P，Church MK，Weller K，et al. Autoimmune chronic spontaneous urticaria：what we know and what we do not know [J]. J Allergy Clin Immunol，2017，139（6）：1772-1781.
[3] Bansal CJ，Bansal AS. Stress，pseudoallergens，autoimmunity，infection and inflammation in chronic spontaneous urticaria [J]. Allergy Asthma Clin Immunol，2019（15）：56.
[4] Rajappa M，Chandrashekar L，Sundar I，et al. Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria [J]. Clin Chem Lab Med，2013，51（9）：1789-1794.
[5] Bracken SJ，Abraham S，MacLeod AS. Autoimmune theories of chronic spontaneous urticaria [J]. Front Immunol，2019（10）：627.
[6] 宿斌，熊志飞，赵炳，等.慢性自发性荨麻疹患者血清维生素D、脱氢表雄酮硫酸酯水平与Th1/Th2细胞因子及免疫球蛋白的关系分析[J].国际检验医学杂志，2020，41（4）：435-439.
[7] Tuchinda P，Kulthanan K，Chularojanamontri L，et al. Relationship between vitamin D and chronic spontaneous urticaria：a systematic review [J]. Clin Transl Allergy，2018， 8（4）：51.
[8] Yanase Y，Takahagi S，Hide M. Chronic spontaneous urticaria and the extrinsic coagulation system [J]. Allergol Int，2018，67（2）：191-194.
[9] Saini SS，Kaplan AP. Chronic spontaneous urticaria：the Devil’s itch [J]. J Allergy Clin Immunol Pract，2018，6（4）：1097-1106.
[10] 戴韵佳，邓丹琪，周娅丽.凝血功能在荨麻疹中意义的研究进展[J].皮肤病与性病，2020，42（5）：665-668.
[11] Lordan R，Tsoupras A，Zabetakis I，et al. Forty years since the structural elucidation of platelet-activating factor（PAF）：historical，current，and future research perspectives [J]. Molecules，2019，24（23）：4414.
[12] Bousquet J，Grattan CE，Akdis CA，et al. Highlights and recent developments in allergic diseases in EAACI journals（2019） [J]. Clin Transl Allergy，2020，10（1）：56.
[13] 孙星，傅继华.过敏性疾病药物治疗研究现状及进展[J].中国医药指南，2011，9（9）：194-196.
[14] Pa?覥gan K，Bartuzi Z. Platelet activating factor in allergies [J]. Int J Immunopathol Pharmacol，2015，28（4）：584-589.
[15] Kato M，Yamaguchi T，Tachibana A. An atypical protein kinase C，PKC，regulates human eosinophil effector functions [J]. Immunology，2005，116（2）：193-202.
[16] Nakamura T，Murata T. Regulation of vascular permeability in anaphylaxis [J]. Br J Pharmacol，2018，175（13）：2538-2542.
[17] 马翔，李潇潇，刘维，等.血小板活化因子在药源性严重过敏反应中的研究现状[J].中国临床药理学杂志，2015， 31（4）：308-311.
[18] 张丽丹，刘炜钰，罗权.卢帕他定治疗荨麻疹的研究进展[J].皮肤性病诊疗学杂志，2016，23（5）：362-364.
[19] Reber LL，Hernandez JD，Galli SJ. The pathophysiology of anaphylaxis [J]. J Allergy Clin Immunol，2017，140（2）：335-348.
[20] 朱奕锜，王朵勤，唐慧，等.血小板活化因子及其乙酰水解酶与荨麻疹的相关性研究[J].中国麻风皮肤病杂志，2018，34（7）：399-402.
[21] 邓卓怡，刘晓玲.血小板活化因子在变应性鼻炎中的作用及其研究进展[J].中国耳鼻咽喉颅底外科杂志，2020， 26（6）：712-716.
[22] Mu?觡oz-Cano RM，Casas-Saucedo R，Valero Santiago A，et al. Platelet-activating factor（PAF）in allergic rhinitis：clinical and therapeutic implications [J]. J Clin Med，2019， 8（9）：1338.
[23] Shamizadeh S，Brockow K，Ring J. Rupatadine：efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects [J]. Allergo J Int，2014，23（3）：87-95.
[24] Mullol J，Bousquet J，Bachert C，et al. Update on rupatadine in the management of allergic disorders [J]. Allergy，2015，70（100）：1-24.
[25] Mullol J，Bousquet J，Bachert C，et al. Rupatadine in allergic rhinitis and chronic urticaria [J]. Allergy，2008，63（87）：5-28.
[26] Munoz-Cano R，Ainsua-Enrich E，Torres-Atencio I，et al. Effects of rupatadine on platelet-activating factor-induced human mast cell degranulation compared with desloratadine and levocetirizine（the MASPAF Study） [J]. J Investig Allergol Clin Immunol，2017，27（3）：161-168.
[27] Simons FER，Sheikh A. Anaphylaxis：the acute episode and beyond [J]. BMJ，2013（346）：1-10.
[28] Spickett G. Urticaria and angioedema [J]. J R Coll Physicians Edinb，2014，44（1）：50-54.
[29] 陈珵，徐侃.血小板在炎症反应中作用的研究进展[J].海南医学，2017，28（4）：623-626.
[30] Pa?覥gan K，Ko?覥akowska J，Zbikowska-Gotz M，et al. The role of mast cells in inflammatory reactions [J]. Pneumonol Alergol Pol，2000，68（11-12）：603-609.
[31] Kajiwara N，Sasaki T，Bradding P. Activation of human mast cells through the platelet-activating factor receptor [J]. J Allergy Clin Immunol，2010，125（5）：1137-1145.
[32] Ashraf MA，Nookala V. Biochemistry，platelet activating factor [M]. Treasure Island：StatPearls Publishing，2020.
[33] 吴迪，梁仁，张萃.血小板活化因子对嗜酸性粒细胞活化作用的实验研究[J].广东药学院学报，2004，20（5）：524-526.